Michael Bruce
Vorstandsvorsitzender bei Exo Therapeutics, Inc.
Aktive Positionen von Michael Bruce
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Exo Therapeutics, Inc.
Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Vorstandsvorsitzender | 01.02.2020 | - |
Karriereverlauf von Michael Bruce
Ehemalige bekannte Positionen von Michael Bruce
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KALEIDO BIOSCIENCES, INC. | Corporate Officer/Principal | 01.10.2017 | 01.02.2020 |
CRISPR THERAPEUTICS AG | Corporate Officer/Principal | 01.01.2015 | 01.01.2017 |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | 01.01.2003 | 01.01.2015 |
PFIZER, INC. | Corporate Officer/Principal | 01.01.2003 | 01.01.2015 |
Ausbildung von Michael Bruce
Williams College | Undergraduate Degree |
Stanford University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Schweiz | 2 |
Operativ
Corporate Officer/Principal | 4 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
CRISPR THERAPEUTICS AG | Health Technology |
KALEIDO BIOSCIENCES, INC. | Health Technology |
PFIZER, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Exo Therapeutics, Inc.
Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Michael Bruce
- Erfahrung